NEWS

Sep 21, 2023

WEBINAR: Cystatin C , Creatinine and eGFR Equations

Cystatin C Webinar Series: CKD-EPI equations Cystatin C is a superior glomerular filtration rate (GFR) marker..

Read more

Aug 11, 2023

New publication - calprotectin is advantageous in the ICU

Early detection of bacterial infections for improved patient management in the ICU Cost-effectiveness of..

Read more

Jun 08, 2023

Calprotectin in acute infections and sepsis for prognosis, characterisation and diagnosis in the ED

Calprotectin in the Emergency Department (ED) We are pleased to present results from a prospective clinical..

Read more

May 16, 2023

Calprotectin in blood, cystatin C, canine CRP @ EuroMedLab

Gentian @ Worldlab-EuroMedLab 2023 We look forward to share insights and news about GCAL® - plasma and serum..

Read more

May 08, 2023

Meet us at WorldLab-EuroMedLab 2023

Meet us at WorldLab-EuroMedLab 2023 We look forward to seeing you at WorldLab–EuroMedLab 22-24 May 2023 in..

Read more

May 02, 2023

Health economic impact of use of GCAL® Calprotectin Immunoassay for early detection of infection in intensive care patients*

The challenge – Early diagnosis of bacterial infections in critically ill patients Early diagnosis of..

Read more

Apr 13, 2023

ECCMID: The value of calprotectin in the Emergency Department

Learn more about the value of calprotectin in the Emergency Department Studies have shown the ability of..

Read more

Mar 15, 2023

ISICEM poster: Health economic benefits from use of calprotectin in ICU patients

Gentian’s CSO Aleksandra Havelka will present the poster “Health economic impact of use of calprotectin..

Read more

Mar 03, 2023

Cystatin C and GCAL® - IVDR implementation completed

The last step of the IVDR implementation completed The Gentian Cystatin C and GCAL® assays have been IVDR..

Read more

Feb 21, 2023

Kidney health: Estimating eGFR without the inclusion of race and sex

Can you estimate Glomerular Filtration Rate (eGFR) without the inclusion of race and sex? The European Kidney..

Read more